title: Different response rates to low-dose cytosine arabinoside in acute myeloid leukemia subtypes.
authors.forename: D
authors.initials: D
authors.lastname: Lutz
authors.forename: O
authors.initials: O
authors.lastname: Krieger
authors.forename: R
authors.initials: R
authors.lastname: Ihle
authors.forename: S
authors.initials: S
authors.lastname: Fekete
authors.forename: H
authors.initials: H
authors.lastname: Minigo
authors.forename: H
authors.initials: H
authors.lastname: Nowotny
authors.forename: H
authors.initials: H
authors.lastname: Kasparu
authors.forename: H
authors.initials: H
authors.lastname: Tüchler
authors.forename: U
authors.initials: U
authors.lastname: Köller
mesh_terms: D000367:Age Factors; D000951:Antigens, Neoplasm / Q000032:analysis; D000954:Antigens, Surface / Q000032:analysis; D002869:Chromosome Aberrations / Q000235:genetics; D025063:Chromosome Disorders; D003561:Cytarabine / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000145:classification / Q000188:drug therapy* / Q000235:genetics; D011379:Prognosis
chemical_list: D000951:Antigens, Neoplasm; D000954:Antigens, Surface; D003561:Cytarabine